GSK Dodges Claims Over Thalidomide Birth Defects
A Pennsylvania federal judge on Thursday dismissed a suit by a man who claimed that his birth defects were caused by his mother's treatment with GlaxoSmithKline LLC's morning-sickness drug thalidomide, finding...To view the full article, register now.
Already a subscriber? Click here to view full article